605 related articles for article (PubMed ID: 25952490)
41. Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
Wen PY
J Clin Oncol; 2010 Apr; 28(12):1977-9. PubMed ID: 20308652
[No Abstract] [Full Text] [Related]
42. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
[TBL] [Abstract][Full Text] [Related]
43. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
[TBL] [Abstract][Full Text] [Related]
44. One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre.
Keogh RJ; Aslam R; Hennessy MA; Coyne Z; Hennessy BT; Breathnach OS; Grogan L; Morris PG
BMC Cancer; 2021 Feb; 21(1):140. PubMed ID: 33557783
[TBL] [Abstract][Full Text] [Related]
45. Aggressive oligodendroglioma: a chemosensitive tumor.
Cairncross JG
Recent Results Cancer Res; 1994; 135():127-33. PubMed ID: 8047688
[No Abstract] [Full Text] [Related]
46. PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas.
Soffietti R; Rudà R; Bradac GB; Schiffer D
Neurosurgery; 1998 Nov; 43(5):1066-73. PubMed ID: 9802850
[TBL] [Abstract][Full Text] [Related]
47. Promises and controversies in the management of low-grade glioma.
Stupp R; Baumert BG
Ann Oncol; 2003 Dec; 14(12):1695-6. PubMed ID: 14630671
[No Abstract] [Full Text] [Related]
48. 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.
Kouwenhoven MC; Kros JM; French PJ; Biemond-ter Stege EM; Graveland WJ; Taphoorn MJ; Brandes AA; van den Bent MJ
Eur J Cancer; 2006 Oct; 42(15):2499-503. PubMed ID: 16914310
[TBL] [Abstract][Full Text] [Related]
49. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
50. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial.
Taphoorn MJ; van den Bent MJ; Mauer ME; Coens C; Delattre JY; Brandes AA; Sillevis Smitt PA; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; Allgeier A; Bottomley A;
J Clin Oncol; 2007 Dec; 25(36):5723-30. PubMed ID: 18089866
[TBL] [Abstract][Full Text] [Related]
51. Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma.
Paleologos NA; Macdonald DR; Vick NA; Cairncross JG
Neurology; 1999 Sep; 53(5):1141-3. PubMed ID: 10496285
[TBL] [Abstract][Full Text] [Related]
52. Oligodendroglial tumor chemotherapy using "decreased-dose-intensity" PCV: a Singapore experience.
Ty AU; See SJ; Rao JP; Khoo JB; Wong MC
Neurology; 2006 Jan; 66(2):247-9. PubMed ID: 16434664
[TBL] [Abstract][Full Text] [Related]
53. Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.
Wang M; Cairncross G; Shaw E; Jenkins R; Scheithauer B; Brachman D; Buckner J; Fink K; Souhami L; Laperriere N; Mehta M; Curran W; ; ; ; ;
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):662-9. PubMed ID: 19783377
[TBL] [Abstract][Full Text] [Related]
54. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
[TBL] [Abstract][Full Text] [Related]
55. High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma.
Abrey LE; Childs BH; Paleologos N; Kaminer L; Rosenfeld S; Salzman D; Finlay JL; Gardner S; Peterson K; Hu W; Swinnen L; Bayer R; Forsyth P; Stewart D; Smith AM; Macdonald DR; Weaver S; Ramsey DA; Nimer SD; DeAngelis LM; Cairncross JG
J Neurooncol; 2003 Nov; 65(2):127-34. PubMed ID: 14686732
[TBL] [Abstract][Full Text] [Related]
56. PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussion.
Villano JL; Wen PY; Lee EQ; Nayak L; Reardon DA; Rosenfeld MR
J Neurooncol; 2013 May; 113(1):143-7. PubMed ID: 23479035
[No Abstract] [Full Text] [Related]
57. The treatment of anaplastic oligodendrogliomas and mixed gliomas.
Kyritsis AP; Yung WK; Bruner J; Gleason MJ; Levin VA
Neurosurgery; 1993 Mar; 32(3):365-70; discussion 371. PubMed ID: 8455760
[TBL] [Abstract][Full Text] [Related]
58. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
[TBL] [Abstract][Full Text] [Related]
59. Kinetic evaluation of low-grade gliomas in adults before and after treatment with CCNU alone.
Kaloshi G; Roci E; Rroji A; Ducray F; Petrela M
J Neurosurg; 2015 Nov; 123(5):1244-6. PubMed ID: 26115464
[TBL] [Abstract][Full Text] [Related]
60. Chemotherapy of low-grade gliomas.
Lesser GJ
Semin Radiat Oncol; 2001 Apr; 11(2):138-44. PubMed ID: 11285551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]